304 related articles for article (PubMed ID: 16825934)
1. Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole.
Giannini EG; Bilardi C; Dulbecco P; Mamone M; Santi ML; Testa R; Mansi C; Savarino V
J Clin Gastroenterol; 2006 Jul; 40(6):515-20. PubMed ID: 16825934
[TBL] [Abstract][Full Text] [Related]
2. A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.
Giannini EG; Bilardi C; Dulbecco P; Mamone M; Santi ML; Testa R; Mansi C; Savarino V
Aliment Pharmacol Ther; 2006 Jan; 23(2):281-7. PubMed ID: 16393308
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
Cammarota G; Cianci R; Cannizzaro O; Cuoco L; Pirozzi G; Gasbarrini A; Armuzzi A; Zocco MA; Santarelli L; Arancio F; Gasbarrini G
Aliment Pharmacol Ther; 2000 Oct; 14(10):1339-43. PubMed ID: 11012480
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults.
Pan X; Li Y; Qiu Y; Tang Q; Qian B; Yao L; Shi R; Zhang G
Clin Ther; 2010 Nov; 32(12):2003-11. PubMed ID: 21118735
[TBL] [Abstract][Full Text] [Related]
5. Use of bovine lactoferrin for Helicobacter pylori eradication.
Di Mario F; Aragona G; Dal Bò N; Cavestro GM; Cavallaro L; Iori V; Comparato G; Leandro G; Pilotto A; Franzè A
Dig Liver Dis; 2003 Oct; 35(10):706-10. PubMed ID: 14620619
[TBL] [Abstract][Full Text] [Related]
6. Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment.
Bosques-Padilla FJ; Garza-González E; Calderón-Lozano IE; Reed-SanRoman G; de Ariño Suárez M; Valdovinos-Díaz MA; Orozco-Gámiz A; Blancas-Valencia JM; Tamayo-de la Cuesta JL
Helicobacter; 2004 Oct; 9(5):417-21. PubMed ID: 15361080
[TBL] [Abstract][Full Text] [Related]
7. High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication.
Cammarota G; Cianci R; Cannizzaro O; Martino A; Fedeli P; Lecca PG; di Caro S; Cesaro P; Branca G; Gasbarrini G
J Clin Gastroenterol; 2004 Feb; 38(2):110-4. PubMed ID: 14745283
[TBL] [Abstract][Full Text] [Related]
8. Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
Wong BC; Wong WM; Yee YK; Hung WK; Yip AW; Szeto ML; Li KF; Lau P; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Hui CK; Lam SK
Aliment Pharmacol Ther; 2001 Dec; 15(12):1959-65. PubMed ID: 11736727
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
[TBL] [Abstract][Full Text] [Related]
10. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication.
Zullo A; Hassan C; De Francesco V; Lorenzetti R; Marignani M; Angeletti S; Ierardi E; Morini S
Dig Liver Dis; 2003 Apr; 35(4):232-6. PubMed ID: 12801033
[TBL] [Abstract][Full Text] [Related]
11. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
Cammarota G; Papa A; Cianci R; Cannizzaro O; Armuzzi A; Gasbarrini A; Addolorato G; Gasbarrini GB
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):247-50. PubMed ID: 10333196
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
[TBL] [Abstract][Full Text] [Related]
13. Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
Gambaro C; Bilardi C; Dulbecco P; Iiritano E; Zentilin P; Mansia C; Usai P; Vigneri S; Savarino V
Dig Liver Dis; 2003 Nov; 35(11):763-7. PubMed ID: 14674665
[TBL] [Abstract][Full Text] [Related]
14. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
Hassan C; De Francesco V; Zullo A; Scaccianoce G; Piglionica D; Ierardi E; Panella C; Morini S
Aliment Pharmacol Ther; 2003 Sep; 18(6):641-6. PubMed ID: 12969091
[TBL] [Abstract][Full Text] [Related]
15. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
Wong WM; Gu Q; Lam SK; Fung FM; Lai KC; Hu WH; Yee YK; Chan CK; Xia HH; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2003 Feb; 17(4):553-60. PubMed ID: 12622764
[TBL] [Abstract][Full Text] [Related]
17. One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.
Wang HH; Chou JW; Liao KF; Lin ZY; Lai HC; Hsu CH; Chen CB
World J Gastroenterol; 2005 Mar; 11(11):1680-4. PubMed ID: 15786549
[TBL] [Abstract][Full Text] [Related]
18. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Nagahara A; Miwa H; Ogawa K; Kurosawa A; Ohkura R; Iida N; Sato N
Helicobacter; 2000 Jun; 5(2):88-93. PubMed ID: 10849057
[TBL] [Abstract][Full Text] [Related]
19. High eradication rates of Helicobacter pylori with a new sequential treatment.
Zullo A; Vaira D; Vakil N; Hassan C; Gatta L; Ricci C; De Francesco V; Menegatti M; Tampieri A; Perna F; Rinaldi V; Perri F; Papadìa C; Fornari F; Pilati S; Mete LS; Merla A; Potì R; Marinone G; Savioli A; Campo SM; Faleo D; Ierardi E; Miglioli M; Morini S
Aliment Pharmacol Ther; 2003 Mar; 17(5):719-26. PubMed ID: 12641522
[TBL] [Abstract][Full Text] [Related]
20. Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages.
Mario FD; Dal Bo N; Aragona G; Moussa AM; Iori V; Cavestro GM; Pilotto A; Leandro G; Franceschi M; Rugge M; Franze A
J Gastroenterol Hepatol; 2003 Jul; 18(7):783-6. PubMed ID: 12795749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
